Advertisement

American Journal of Clinical Dermatology

, Volume 7, Issue 1, pp 1–5 | Cite as

The Mystery of Morgellons Disease

Infection or Delusion?
  • Virginia R. Savely
  • Mary M. Leitao
  • Raphael B. Stricker
Current Opinion

Abstract

Morgellons disease is a mysterious skin disorder that was first described more than 300 years ago. The disease is characterized by fiber-like strands extruding from the skin in conjunction with various dermatologic and neuropsychiatric symptoms. In this respect, Morgellons disease resembles and may be confused with delusional parasitosis. The association with Lyme disease and the apparent response to antibacterial therapy suggest that Morgellons disease may be linked to an undefined infectious process. Further clinical and molecular research is needed to unlock the mystery of Morgellons disease.

Keywords

Skin Lesion Down Syndrome Osteogenesis Imperfecta Lyme Disease Ivermectin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This work was supported in part by the Morgellons Research Foundation (McMurray, PA, USA) and the International Lyme and Associated Diseases Society (ILADS; Bethesda, MD, USA). The authors thank Drs J. Kurt Frederick, Alan MacDonald, Steven Phillips, Joseph Burrascano, Kenneth Liegner, Richard Horowitz, and Ann Corson for helpful discussion; Charles Holman for providing figures used in the article; and Diane Gay for patient care. The authors declare that they have no conflicts of interest related to the contents of this article.

References

  1. 1.
    Ait-Ameur A, Bern P, Firoloni MP, et al. Delusional parasitosis or Ekbom’s syndrome. Rev Med Interne. 2000; 21: 182–6CrossRefPubMedGoogle Scholar
  2. 2.
    Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis: general discussion and case illustrations. Dermatol Clin. 1996; 14: 429–38CrossRefPubMedGoogle Scholar
  3. 3.
    Koo J, Lee CS. Delusions of parasitosis: a dermatologist’s guide to diagnosis and treatment. Am J Clin Dermatol. 2001; 2: 285–90CrossRefPubMedGoogle Scholar
  4. 4.
    Wilson FC, Uslan DZ. Delusional parasitosis. Mayo Clin Proc. 2004; 79: 1470CrossRefPubMedGoogle Scholar
  5. 5.
    Bourgeois ML, Duhamel P, Verdoux H. Delusional parasitosis: folie à deux and attempted murder of a family doctor. Br J Psychiatry. 1992; 161: 709–11CrossRefPubMedGoogle Scholar
  6. 6.
    Daniel E, Srinivasan TN. Folie à famille: delusional parasitosis affecting all the members of a family. Indian J Dermatol Venereol Leprol. 2004; 70: 296–7PubMedGoogle Scholar
  7. 7.
    Lorenzo CR, Koo J. Pimozide in dermatologic practice: a comprehensive review. Am J Clin Dermatol 2004; 5: 339–49CrossRefPubMedGoogle Scholar
  8. 8.
    Kellett CE. Sir Thomas Browne and the disease called the Morgellons. Ann Med Hist. 1935; 7: 467–9Google Scholar
  9. 9.
    Hall DA, Happey F, Lloyd PF, et al. Oriented cellulose as a component of mammalian tissue. Proc R Soc Lond B Biol Sci. 1960; 151: 497–516CrossRefPubMedGoogle Scholar
  10. 10.
    Matthysse AG, White S, Lightfoot R. Genes required for cellulose synthesis in Agrobacterium tumefaciens. J Bacteriol. 1995; 177: 1069–75PubMedGoogle Scholar
  11. 11.
    Bertocchi C, Delneri D, Signore S, et al. Characterization of microbial cellulose from a high-producing mutagenized Acetobacter pasteurianus strain. Biochim Biophys Acta. 1997; 1336: 211–7CrossRefPubMedGoogle Scholar
  12. 12.
    Brown RM. Cellulose structure and biosynthesis. Pure Appl Chem. 1999; 71: 204–12Google Scholar
  13. 13.
    Polizeli ML, Rizzatti AC, Monti R, et al. Xylanases from fungi: properties and industrial applications. Appl Microbiol Biotechnol. 2005; 67: 577–91CrossRefPubMedGoogle Scholar
  14. 14.
    Wang D. Carbohydrate microarrays. Proteomics. 2003; 3: 2167–5CrossRefPubMedGoogle Scholar
  15. 15.
    Melrose WD. Lymphatic filariasis: new insights into an old disease. Int J Parasitol. 2002; 32: 947–60CrossRefPubMedGoogle Scholar
  16. 16.
    Melrose WD. Chemotherapy for lymphatic filariasis: progress but not perfection. Expert Rev Anti Infect Ther 2003; 1: 571–7CrossRefPubMedGoogle Scholar
  17. 17.
    Sehgal VN, Jain S, Thappa DM, et al. Perforating dermatoses: a review and report of four cases. J Dermatol. 1993; 20: 329–40PubMedGoogle Scholar
  18. 18.
    Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis: evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol. 1989; 125: 1074–8CrossRefPubMedGoogle Scholar
  19. 19.
    Mehta RK, Burrows NP, Payne CM, et al. Elastosis perforans serpiginosa and associated disorders. Clin Exp Dermatol. 2001; 26: 521–4CrossRefPubMedGoogle Scholar
  20. 20.
    Becuwe C, Dalle S, Ronger-Savle S, et al. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson’s disease with penicillamine. Dermatology. 2005; 210: 60–3CrossRefPubMedGoogle Scholar
  21. 21.
    Kuhn TS. The structure of scientific revolutions. 2nd ed. Chicago (IL): University of Chicago Press}, 1Google Scholar
  22. 22.
    Koo J, Gambla C, Fried R. Pseudopsychodermatologic disease. Dermatol Clin. 1996; 14: 525–30CrossRefPubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • Virginia R. Savely
    • 1
  • Mary M. Leitao
    • 2
  • Raphael B. Stricker
    • 3
  1. 1.South Austin Family Practice ClinicAustinUSA
  2. 2.Morgellons Research FoundationMcMurrayUSA
  3. 3.California Pacific Medical CenterSan FranciscoUSA

Personalised recommendations